| 000 | 01584 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516205427.0 | ||
| 264 | 0 | _c20150223 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1941-837X | ||
| 024 | 7 |
_a10.3111/13696998.2014.914033 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRule, Simon | |
| 245 | 0 | 0 |
_aSubcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom. _h[electronic resource] |
| 260 |
_bJournal of medical economics _cJul 2014 |
||
| 300 |
_a459-68 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdministration, Intravenous _xeconomics |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 |
_aHealth Personnel _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInjections, Subcutaneous _xeconomics |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 |
_aOutpatient Clinics, Hospital _xeconomics |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aState Medicine _xeconomics |
| 650 | 0 | 4 | _aTime and Motion Studies |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aCollins, Graham P | |
| 700 | 1 | _aSamanta, Kunal | |
| 773 | 0 |
_tJournal of medical economics _gvol. 17 _gno. 7 _gp. 459-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3111/13696998.2014.914033 _zAvailable from publisher's website |
| 999 |
_c23726178 _d23726178 |
||